companies / plakoustherapeutics-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-08 json
| total_raised | 2,098,2192.1M | ○ |
|---|---|---|
| founded | null | |
| hq | WINSTON SALEM, North Carolina | |
| industry | unknown | |
| stage | null |
Plakous Therapeutics develops human-placental-extract biotherapeutics with anti-inflammatory and cell-proliferation activity. Lead programmes target paediatric necrotising enterocolitis and infant malabsorption with rare-paediatric and orphan-drug designations. The platform repositions birth-tissue extracts as a regenerative-medicine class.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-01-01 | grant | 2,098,2192.1M | null | ○ |
Nginx, WordPress, Typekit, Adobe Fonts, AitThemes, MonsterInsights 10.1.3, Yoast SEO 27.5, reCAPTCHA, Google Analytics, Google Tag Manager, Gravity Forms 2.10.1, jQuery Migrate 3.4.1
| fact | status | src |
|---|---|---|
| Grant, $2.1M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |